174 related articles for article (PubMed ID: 20955150)
1. Triterpene derivatives as inhibitors of protein involved in the inflammatory process: molecules interfering with phospholipase A2, cycloxygenase, and lipoxygenase.
Braca A; Dal Piaz F; Marzocco S; Autore G; Vassallo A; De Tommasi N
Curr Drug Targets; 2011 Mar; 12(3):302-21. PubMed ID: 20955150
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological evaluation and docking studies of α,β-unsaturated carbonyl based synthetic compounds as inhibitors of secretory phospholipase A₂, cyclooxygenases, lipoxygenase and proinflammatory cytokines.
Bukhari SN; Lauro G; Jantan I; Bifulco G; Amjad MW
Bioorg Med Chem; 2014 Aug; 22(15):4151-61. PubMed ID: 24938495
[TBL] [Abstract][Full Text] [Related]
3. Studies of synthetic chalcone derivatives as potential inhibitors of secretory phospholipase A2, cyclooxygenases, lipoxygenase and pro-inflammatory cytokines.
Jantan I; Bukhari SN; Adekoya OA; Sylte I
Drug Des Devel Ther; 2014; 8():1405-18. PubMed ID: 25258510
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and biological evaluation of some novel indolizine derivatives as dual cyclooxygenase and lipoxygenase inhibitor for anti-inflammatory activity.
Shrivastava SK; Srivastava P; Bandresh R; Tripathi PN; Tripathi A
Bioorg Med Chem; 2017 Aug; 25(16):4424-4432. PubMed ID: 28669741
[TBL] [Abstract][Full Text] [Related]
5. Chemistry and biology of anti-inflammatory marine natural products: molecules interfering with cyclooxygenase, NF-kappaB and other unidentified targets.
Terracciano S; Aquino M; Rodriquez M; Monti MC; Casapullo A; Riccio R; Gomez-Paloma L
Curr Med Chem; 2006; 13(16):1947-69. PubMed ID: 16842204
[TBL] [Abstract][Full Text] [Related]
6. Computer-aided discovery of anti-inflammatory thiazolidinones with dual cyclooxygenase/lipoxygenase inhibition.
Geronikaki AA; Lagunin AA; Hadjipavlou-Litina DI; Eleftheriou PT; Filimonov DA; Poroikov VV; Alam I; Saxena AK
J Med Chem; 2008 Mar; 51(6):1601-9. PubMed ID: 18311898
[TBL] [Abstract][Full Text] [Related]
7. Chromones: A Promising Ring System for New Anti-inflammatory Drugs.
Silva CF; Pinto DC; Silva AM
ChemMedChem; 2016 Oct; 11(20):2252-2260. PubMed ID: 27630077
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of arachidonic acid metabolism by the Andean crude drug Parastrephia lucida (Meyen) Cabrera.
D'Almeida RE; Isla MI; Vildoza Ede L; Quispe C; Schmeda-Hirschmann G; Alberto MR
J Ethnopharmacol; 2013 Dec; 150(3):1080-6. PubMed ID: 24432370
[TBL] [Abstract][Full Text] [Related]
9. Triterpene Acids from Frankincense and Semi-Synthetic Derivatives That Inhibit 5-Lipoxygenase and Cathepsin G.
Koeberle A; Henkel A; Verhoff M; Tausch L; König S; Fischer D; Kather N; Seitz S; Paul M; Jauch J; Werz O
Molecules; 2018 Feb; 23(2):. PubMed ID: 29495286
[TBL] [Abstract][Full Text] [Related]
10. Dual acting anti-inflammatory drugs: a reappraisal.
Bertolini A; Ottani A; Sandrini M
Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
[TBL] [Abstract][Full Text] [Related]
11. Recent development in the field of dual COX / 5-LOX inhibitors.
Julémont F; Dogné JM; Pirotte B; de Leval X
Mini Rev Med Chem; 2004 Aug; 4(6):633-8. PubMed ID: 15279597
[TBL] [Abstract][Full Text] [Related]
12. Outstanding Anti-inflammatory Potential of Selected Asteraceae Species through the Potent Dual Inhibition of Cyclooxygenase-1 and 5-Lipoxygenase.
Chagas-Paula DA; Oliveira TB; Faleiro DP; Oliveira RB; Costa FB
Planta Med; 2015 Sep; 81(14):1296-307. PubMed ID: 26227502
[TBL] [Abstract][Full Text] [Related]
13. Anti-inflammatory drugs: new multitarget compounds to face an old problem. The dual inhibition concept.
Celotti F; Laufer S
Pharmacol Res; 2001 May; 43(5):429-36. PubMed ID: 11394934
[TBL] [Abstract][Full Text] [Related]
14. Known Triterpenes and their Derivatives as Scaffolds for the Development of New Therapeutic Agents for Cancer.
Peron G; Marzaro G; Dall Acqua S
Curr Med Chem; 2018; 25(10):1259-1269. PubMed ID: 28820068
[TBL] [Abstract][Full Text] [Related]
15. [Controlling arachidonic acid metabolic network: from single- to multi-target inhibitors of key enzymes].
Liu Y; Chen Z; Shang EC; Yang K; Wei DG; Zhou L; Jiang XL; He C; Lai LH
Yao Xue Xue Bao; 2009 Mar; 44(3):231-41. PubMed ID: 19449519
[TBL] [Abstract][Full Text] [Related]
16. Ruthenium(ii) arene NSAID complexes: inhibition of cyclooxygenase and antiproliferative activity against cancer cell lines.
Mandal P; Kundu BK; Vyas K; Sabu V; Helen A; Dhankhar SS; Nagaraja CM; Bhattacherjee D; Bhabak KP; Mukhopadhyay S
Dalton Trans; 2018 Jan; 47(2):517-527. PubMed ID: 29235601
[TBL] [Abstract][Full Text] [Related]
17. Structure-Activity Relationships of Pentacyclic Triterpenoids as Inhibitors of Cyclooxygenase and Lipoxygenase Enzymes.
Vo NNQ; Nomura Y; Muranaka T; Fukushima EO
J Nat Prod; 2019 Dec; 82(12):3311-3320. PubMed ID: 31774676
[TBL] [Abstract][Full Text] [Related]
18. New cyclooxygenase-2/5-lipoxygenase inhibitors. 3. 7-tert-butyl-2, 3-dihydro-3,3-dimethylbenzofuran derivatives as gastrointestinal safe antiinflammatory and analgesic agents: variations at the 5 position.
Janusz JM; Young PA; Ridgeway JM; Scherz MW; Enzweiler K; Wu LI; Gan L; Chen J; Kellstein DE; Green SA; Tulich JL; Rosario-Jansen T; Magrisso IJ; Wehmeyer KR; Kuhlenbeck DL; Eichhold TH; Dobson RL
J Med Chem; 1998 Aug; 41(18):3515-29. PubMed ID: 9719605
[TBL] [Abstract][Full Text] [Related]
19. Inhibitors of prostaglandin synthesis inhibit human prostate tumor cell invasiveness and reduce the release of matrix metalloproteinases.
Attiga FA; Fernandez PM; Weeraratna AT; Manyak MJ; Patierno SR
Cancer Res; 2000 Aug; 60(16):4629-37. PubMed ID: 10969817
[TBL] [Abstract][Full Text] [Related]
20. Multiple target-centric strategy to tame inflammation.
Kaur G; Silakari O
Future Med Chem; 2017 Aug; 9(12):1361-1376. PubMed ID: 28771028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
